Clinical Trials Browser

Phase 1/2 × HER2-positive Early Breast Cancer × Docetaxel × Clear all

NCT04750122 2021-04-01

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients

Phase 1/2 Recruiting

HER2-positive Early Breast Cancer